InvestorsHub Logo

Titan V

03/28/17 3:54 PM

#210239 RE: RockRat #210238

I find it odd too, going up so much on just IND approval alone. I wouldn't be surprised if there's a sharp drop tomorrow with or without an offering.

nsomniyak

03/28/17 11:19 PM

#210258 RE: RockRat #210238

You might have more ways to play CBIO tomorrow, as the CBOE will likely open up some options at higher strike prices (and maybe further out than April as well). I agree that none of the potential options plays made sense today.

DewDiligence

12/20/17 9:52 AM

#216153 RE: RockRat #210238

CBIO sells 1.27M* shares @$9.50—a 5% discount to yesterday’s close:

https://finance.yahoo.com/news/catalyst-biosciences-announces-pricing-public-141156154.html

*Assuming exercise of underwriter’s option.